Comparison of the Time to Reach End-Tidal Oxygen Value of 90 and Oxygen Reserve Index Decline Times During Preoxygenation in Sarcopenic and Non-Sarcopenic Patients
1 other identifier
observational
80
1 country
1
Brief Summary
The purpose of this study is to compare the time required to reach an end-tidal oxygen (EtO2) value of 90% and the time until the Oxygen Reserve Index (ORI) drops below 0.55 during preoxygenation in sarcopenic and non-sarcopenic patients. The study aims to investigate the impact of sarcopenia on the oxygenation process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2025
CompletedFirst Posted
Study publicly available on registry
February 26, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedFebruary 26, 2025
February 1, 2025
3 months
February 18, 2025
February 21, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Time required to reach EtO2 90%
preoperatively
Time until ORI drops below 0.55
preoperatively
Study Arms (2)
sarcopenic
sarcopenia based on the 6-minute walk test results.
non-sarcopenic
non-sarcopenia based on the 6-minute walk test results.
Interventions
The time required to reach EtO2 90% and the time until ORI drops below 0.55
Eligibility Criteria
80 patients who agreed to participate in the study and are scheduled for major abdominal oncological surgery will be included in the study.
You may qualify if:
- Patients who agree to participate in the study.
- Patients scheduled for major abdominal oncologic surgery.
You may not qualify if:
- Patients with severe cardiopulmonary disease.
- Patients with walking disabilities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara City Hospital Bilkent
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ankara Bilkent City Hospital
Study Record Dates
First Submitted
February 18, 2025
First Posted
February 26, 2025
Study Start
March 1, 2025
Primary Completion
May 30, 2025
Study Completion
August 31, 2025
Last Updated
February 26, 2025
Record last verified: 2025-02